Northcape Wealth Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$293K Hold
1,100
0.08% 122
2025
Q4
$276K Hold
1,100
0.08% 126
2025
Q3
$316K Sell
1,100
-282
-20% -$75.6K 0.09% 119
2025
Q2
$363K Hold
1,382
0.11% 108
2025
Q1
$322K Hold
1,382
0.1% 112
2024
Q4
$317K Hold
1,382
0.1% 115
2024
Q3
$309K Hold
1,382
0.1% 113
2024
Q2
$281K Hold
1,382
0.1% 115
2024
Q1
$302K Hold
1,382
0.11% 111
2023
Q4
$314K Hold
1,382
0.11% 115
2023
Q3
$278K Sell
1,382
-227
-14% -$47.9K 0.11% 122
2023
Q2
$334K Hold
1,609
0.12% 121
2023
Q1
$317K Buy
+1,609
New +$331K 0.11% 123
2022
Q4
Sell
-1,667
Closed -$293K 104
2022
Q3
$293K Hold
1,667
0.1% 116
2022
Q2
$336K Sell
1,667
-58
-3% -$12.4K 0.13% 93
2022
Q1
$391K Hold
1,725
0.11% 111
2021
Q4
$466K Buy
+1,725
New +$427K 0.16% 84

Other funds holding LH

Northcape Wealth Management's LH Position: Q1 2026 in Review

Northcape Wealth Management held its Labcorp (LH) position steady in Q1 2026 at 1,100 shares worth $293K. The position accounts for 0.08% of the portfolio, ranked #122.

Northcape Wealth Management first reported a position in LH in Q4 2021 and has held it in 17 quarters since. The position peaked at $466K in Q4 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Northcape Wealth Management held 1,100 shares of Labcorp worth $293K as of Q1 2026.
  • Northcape Wealth Management left its Labcorp share count unchanged in Q1 2026.
  • Labcorp made up 0.08% of Northcape Wealth Management's portfolio in Q1 2026, its #122 holding.
  • Northcape Wealth Management first reported a position in Labcorp in Q4 2021 and has held it in 17 quarters since.
  • Northcape Wealth Management's Labcorp position peaked at $466K in Q4 2021.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Northcape Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.